Respiratory syncytial virus (RSV) is a human respiratory pathogen which remains a leading
viral cause of hospitalizations and mortality among infants in their first year of life. Here, we …

Airway mucus is a hallmark of respiratory syncytial virus (RSV) lower respiratory tract illness.
Laboratory RSV strains differentially induce airway mucus production in mice. Here, we …

Respiratory syncytial virus (RSV) is the most commonly identified viral agent of acute
respiratory tract infection (ARI) of young children and causes repeat infections throughout …

The variability between respiratory syncytial virus (RSV) strains is one of the features of RSV
infections that might contribute to the ability of the virus to infect people repeatedly and …

The respiratory syncytial virus (RSV) is a serious pediatric pathogen for which there is
currently no clinically approved vaccine. This report describes the design and testing of a …

Objectives Despite the optimization of the zero-COVID policy in late 2022, there was a
subsequent increase noted in the number of respiratory syncytial virus (RSV) cases in …

A significant number of children die each year from acute respiratory tract infections
especially in developing countries. Human respiratory syncytial virus (RSV) is the most …

The epidemiology and genetic variability of circulating respiratory syncytial virus (RSV)
strains in Stockholm during the season 2002–2003 were studied in consecutive RSV …

Human respiratory syncytial virus (HRSV) strains were isolated from nasopharyngeal
aspirates collected from 965 children between 2004 and 2005, yielding 424 positive …

Genotyping of respiratory syncytial (RS) virus group A, by means of a novel method based
on PCR, FRET (fluorescence resonance energy transmission) detection and two …